<SEC-DOCUMENT>0001193125-20-227082.txt : 20200821
<SEC-HEADER>0001193125-20-227082.hdr.sgml : 20200821
<ACCEPTANCE-DATETIME>20200821164856
ACCESSION NUMBER:		0001193125-20-227082
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20200821
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200821
DATE AS OF CHANGE:		20200821

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CVS HEALTH Corp
		CENTRAL INDEX KEY:			0000064803
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				050494040
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01011
		FILM NUMBER:		201123985

	BUSINESS ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895
		BUSINESS PHONE:		4017651500

	MAIL ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CAREMARK CORP
		DATE OF NAME CHANGE:	20070509

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS/CAREMARK CORP
		DATE OF NAME CHANGE:	20070322

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CORP
		DATE OF NAME CHANGE:	19970128
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d54415d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cvs="http://www.cvshealth.com/20200821" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body>
 <div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2020-08-21_to_2020-08-21">CVS HEALTH Corp</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2020-08-21_to_2020-08-21">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2020-08-21_to_2020-08-21">0000064803</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="cvs-20200821.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2020-08-21_to_2020-08-21"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-08-21</xbrli:startDate> <xbrli:endDate>2020-08-21</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2020-08-21_to_2020-08-21">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of The Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2020-08-21_to_2020-08-21" format="ixt:datemonthdayyearen">August&#160;21, 2020</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">
<img src="g54415g27f51.jpg" alt="LOGO" /></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">CVS HEALTH CORPORATION</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2020-08-21_to_2020-08-21" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2020-08-21_to_2020-08-21">001-01011</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2020-08-21_to_2020-08-21">05-0494040</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2020-08-21_to_2020-08-21">One CVS Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2020-08-21_to_2020-08-21">Woonsocket</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2020-08-21_to_2020-08-21" format="ixt-sec:stateprovnameen">Rhode Island</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2020-08-21_to_2020-08-21">02895</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2020-08-21_to_2020-08-21">(401)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2020-08-21_to_2020-08-21">765-1500</ix:nonNumeric></span></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Former name or former address, if changed since last report: N/A</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2020-08-21_to_2020-08-21" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2020-08-21_to_2020-08-21" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2020-08-21_to_2020-08-21" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2020-08-21_to_2020-08-21" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:35%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:31%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2020-08-21_to_2020-08-21">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2020-08-21_to_2020-08-21">CVS</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2020-08-21_to_2020-08-21" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2020-08-21_to_2020-08-21" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Section&#160;8 - Other Events </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:12%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;8.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&#160;21, 2020, CVS Health Corporation, a Delaware corporation (the &#8220;Company&#8221; or &#8220;CVS Health&#8221;), issued and sold $1,500,000,000 aggregate principal amount of the Company&#8217;s 1.300% Senior Notes due 2027 (the &#8220;2027 Notes&#8221;), $1,250,000,000 aggregate principal amount of the Company&#8217;s 1.750% Senior Notes due 2030 (the &#8220;2030 Notes&#8221;) and $1,250,000,000 aggregate principal amount of the Company&#8217;s 2.700% Senior Notes due 2040 (the &#8220;2040 Notes&#8221; and, together with the 2027 Notes and the 2030 Notes, the &#8220;Notes&#8221;). The Notes were offered pursuant to the Company&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-3ASR,</span> File <span style="white-space:nowrap">No.&#160;333-238506,</span> dated May&#160;19, 2020 (the &#8220;Registration Statement&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes are governed by and issued pursuant to a Senior Indenture dated August&#160;15, 2006 between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the &#8220;Senior Indenture&#8221;). The Company may issue additional senior debt securities from time to time pursuant to the Senior Indenture. The Senior Indenture was filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form <span style="white-space:nowrap">8-K</span> filed on August&#160;15, 2006 and shall be incorporated by reference into this Current Report on Form <span style="white-space:nowrap">8-K.</span> Forms of the Notes are filed as Exhibits 4.1, 4.2 and 4.3 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and are incorporated by reference into the Registration Statement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Section</span><span style="font-weight:bold"></span><span style="font-weight:bold">&#160;9</span>&#160;&#8211;<span style="font-weight:bold">&#160;Financial Statements and Exhibits</span> </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:12%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(d)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="text-decoration:underline">Exhibits</span>. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The exhibits to this Current Report on Form <span style="white-space:nowrap">8-K</span> are as follows: </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">INDEX TO EXHIBITS </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:6%"></td>
<td style="width:91%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:10pt; font-family:Times New Roman;font-weight:bold">Exhibit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;4.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d54415dex41.htm">Form of the 2027 Note. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;4.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d54415dex42.htm">Form of the 2030 Note. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;4.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d54415dex43.htm">Form of the 2040 Note. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;5.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d54415dex51.htm">Opinion of Shearman&#160;&amp; Sterling LLP. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d54415dex51.htm">Consent of Shearman&#160;&amp; Sterling LLP (included in Exhibit 5.1). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">CVS HEALTH CORPORATION</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: August&#160;21, 2020</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ <span style="font-style:italic">Colleen M. McIntosh</span></p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Colleen M. McIntosh</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Senior Vice President, Chief Governance Officer and Corporate Secretary</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>d54415dex41.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (&#147;DTC&#148;) TO THE COMPANY OR ITS
AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO
CEDE&nbsp;&amp; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS AND UNTIL THIS GLOBAL NOTE IS EXCHANGED IN WHOLE OR IN PART FOR A GLOBAL NOTE IN
DEFINITIVE REGISTERED FORM, THIS GLOBAL NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC OR BY DTC OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH
SUCCESSOR DEPOSITARY. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS HEALTH CORPORATION </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">No.&nbsp;[&#149;]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">$[&#149;]</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CUSIP No.&nbsp;126650 DM9 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISIN
No.&nbsp;US126650DM98 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1.300% Senior Note due 2027 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CVS HEALTH CORPORATION, a Delaware corporation (such corporation, and its successors and assigns under the Indenture hereinafter referred to,
being herein called the &#147;<B>Company</B>&#148;), for value received promises to pay to CEDE&nbsp;&amp; CO., or registered assigns, the principal sum of $[&#149;] on August&nbsp;21, 2027. If such maturity date is not a Business Day, then payment
of principal will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such maturity date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest Payment Dates: February&nbsp;21 and August 21. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Record Dates: Each February&nbsp;6 and August&nbsp;6, immediately preceding each Interest Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional provisions of this Note are set forth on the reverse side of this Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Note to be duly executed. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CVS HEALTH CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Note No. [</I><I></I>&#9679;<I></I><I></I><I>] of 2027 Note</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: August&nbsp;21, 2020 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRUSTEE&#146;S CERTIFICATE OF AUTHENTICATION </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE BANK OF NEW
YORK MELLON TRUST COMPANY, N.A., </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">as Trustee, certifies that this is one of the Debt Securities referred to in the Indenture.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Note No. [</I><I></I>&#9679;<I></I><I></I><I>] of 2027 Note</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1.300% Senior Note due 2027 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note is one of a duly authorized series of Notes of the Company, designated as its 1.300% Senior Notes due 2027 (hereinafter referred to
as the &#147;<B>Notes</B>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Interest </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company promises to pay interest on the principal amount of this Note at the rate per annum shown above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will pay interest on the Notes semi-annually on February&nbsp;21 and August&nbsp;21 of each year, commencing February&nbsp;21,
2021. Interest on the Notes will accrue from the most recent date to which interest has been paid or provided for, or, if no interest has been paid or provided for, from August&nbsp;21, 2020. Interest will be computed on the basis of a <FONT
STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day&nbsp;months.</FONT> The Company shall pay interest on overdue principal at the rate borne by the Notes. If any interest payment date is not a Business
Day, then payment of interest will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such interest payment date to the date payment is made. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Method of Payment </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company will pay interest on the Notes (except defaulted interest) to the Persons who are registered Holders thereof at the close of business on the February&nbsp;6 and August&nbsp;6 (whether or not a Business Day) immediately preceding the interest
payment date even if the Notes are canceled after the record date and on or before the interest payment date. Holders must surrender Notes to a Paying Agent to collect principal payments. The Company will pay principal, premium, if any, and interest
in money of the United States that at the time of payment is legal tender for payment of public and private debts by wire transfer of immediately available funds to the accounts specified by the Holders, or, if no such account is specified, the
Company may pay principal and interest by check payable in such money. It may mail an interest check to a Holder&#146;s registered address. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Paying Agent and Registrar </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Initially, The Bank of New York Mellon Trust Company, N.A., a national banking association (the &#147;<B>Trustee</B>&#148;), will act as
Paying Agent and Registrar. The Company may appoint and change any Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar</FONT> without notice. The Company or any of its domestically incorporated Wholly Owned Subsidiaries may act
as Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar.</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Indenture </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company issued the Notes under an Indenture dated as of August&nbsp;15, 2006 (the &#147;<B>Indenture</B>&#148;), between the Company and
the Trustee. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. ss.ss. 77aaa-77bbbb) as in effect on the date of the Indenture (the
&#147;<B>TIA</B>&#148;). Terms defined in the Indenture and not otherwise defined herein have the respective meanings ascribed thereto in the Indenture. The Notes are subject to all such terms, and Holders of Notes are referred to the Indenture and
the TIA for a statement of those terms. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are general unsecured senior obligations of the Company initially limited to
$1,500,000,000 aggregate principal amount (subject to Section&nbsp;2.08 of the Indenture). The Company may at any time issue additional Notes under the Indenture in unlimited amounts having the same terms as and treated as a single class with the
Notes for all purposes under the Indenture and that will vote together as one class with respect to the Notes. The Indenture imposes certain limitations on the incurrence of certain additional indebtedness by the Company and certain of its
subsidiaries and the entry into certain sale and leaseback arrangements by the Company and certain of its subsidiaries. The Indenture also restricts the ability of the Company to consolidate or merge with or into, or to transfer all or substantially
all its assets to, another person. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Optional Redemption </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to June&nbsp;21, 2027 (for purposes of this Note, the &#147;<B>Applicable Par Call Date</B>&#148;), the Company, at its option, may at
any time redeem all or any portion of the Notes upon not less than 10 nor more than 60 days&#146; notice at a redemption price, plus accrued and unpaid interest, if any, to, but excluding, the redemption date, equal to the greater of (i)&nbsp;100%
of the aggregate principal amount of the Notes being redeemed or (ii)&nbsp;the sum of the present values of the remaining scheduled payments of principal and interest on the Notes being redeemed that would be due if the Notes matured on the
Applicable Par Call Date (not including any portion of such payments of interest accrued to the redemption date) discounted to the redemption date on a semiannual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of
twelve <FONT STYLE="white-space:nowrap">30-day&nbsp;months)</FONT> at the applicable Treasury Yield plus 15 basis points. On or after the Applicable Par Call Date, the Company, at its option, may at any time redeem all or any portion of the Notes
upon not less than 10 nor more than 60 days&#146; notice at a redemption price equal to 100% of the aggregate principal amount of the Notes being redeemed plus accrued and unpaid interest, if any, to, but excluding, the redemption date on such
Notes. If any redemption date is not a Business Day, then payment of the redemption price and accrued and unpaid interest will be made on the next succeeding Business Day, and no interest will accrue on the amounts so payable for the period from
such redemption date to the date payment is made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Comparable Treasury Issue</B>&#148; means the United States Treasury security
selected by an Independent Investment Banker as having a maturity comparable to the remaining term of the Notes (assuming, for this purpose, that the Notes matured on the Applicable Par Call Date) that would be utilized, at the time of selection and
in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to such remaining term. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Comparable Treasury Price</B>&#148; means, with respect to any redemption date for the Notes, (i)&nbsp;the average of the applicable
Reference Treasury Dealer Quotations for such redemption date, after excluding the highest and lowest such applicable Reference Treasury Dealer Quotations, or (ii)&nbsp;if the Independent Investment Banker obtains fewer than four such Reference
Treasury Dealer Quotations, the average of all such Reference Treasury Dealer Quotations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Independent Investment Banker</B>&#148; means Barclays Capital Inc. or, if such
firm is unwilling or unable to select the applicable Comparable Treasury Issue, an independent investment banking institution of national standing appointed by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Reference Treasury Dealer</B>&#148; means (i)&nbsp;Barclays Capital Inc., BofA Securities, Inc. and Goldman Sachs&nbsp;&amp; Co. LLC
and their respective successors; <I>provided</I>, <I>however</I>, that if any of the foregoing shall cease to be a primary United States government securities dealer in New York City (a &#147;<B>Primary Treasury Dealer</B>&#148;), the Company shall
substitute therefor another Primary Treasury Dealer and (ii)&nbsp;any other Primary Treasury Dealer selected by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Reference Treasury Dealer Quotations</B>&#148; means, with respect to each Reference Treasury Dealer and any redemption date for the
Notes, the average, as determined by the Independent Investment Banker, of the bid and asked prices for the Comparable Treasury Issue for the Notes (expressed as a percentage of the aggregate principal amount of the Comparable Treasury Issue) quoted
in writing to the Independent Investment Banker by such Reference Treasury Dealer at 5:00&nbsp;p.m., New York City time, on the third business day preceding such redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Treasury Yield</B>&#148; means, with respect to any redemption date for the Notes, the rate per annum equal to the semiannual
equivalent yield to maturity of the Comparable Treasury Issue for the Notes, assuming a price for the Comparable Treasury Issue (expressed as a percentage of the aggregate principal amount of the Comparable Treasury Issue) equal to the applicable
Comparable Treasury Price for such redemption date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Notice of Optional Redemption </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of redemption shall be transmitted by the Company (or, at the Company&#146;s request, by the Trustee on the Company&#146;s behalf) to
each Holder of Notes to be redeemed. Notes in denominations larger than $2,000 may be redeemed in part but only in whole multiples of $1,000. If money sufficient to pay the redemption price of and accrued interest on all Notes (or portions thereof)
to be redeemed on the redemption date is deposited with the Paying Agent on or before the redemption date and certain other conditions are satisfied, on and after such date interest ceases to accrue on such Notes (or such portions thereof) called
for redemption. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Repurchase of the Notes Upon a Change of Control Triggering Event </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a Change of Control Triggering Event (as defined below) occurs, Holders of the Notes will have the right to require the Company to
repurchase all or any part (in integral multiples of $1,000 up to the original principal amount) of their Notes pursuant to the offer described below (the &#147;<B>Change of Control Offer</B>&#148;) on the terms set forth in this Note. In the Change
of Control Offer, the Company will be required to offer payment in cash equal to 101% of the aggregate principal amount of Notes repurchased plus accrued and unpaid interest, if any, on the Notes repurchased, to, but excluding, the date of purchase
(the &#147;<B>Change of Control Payment</B>&#148;). Within 30 days following any Change of Control Triggering Event, the Company will be required to mail a notice to Holders of Notes describing the transaction or transactions that constitute the
Change of Control Triggering Event and offering to repurchase the Notes on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
notice is mailed (the &#147;<B>Change of Control Payment Date</B>&#148;), pursuant to the procedures required by this Note and described in such notice. The Company must comply with the
requirements of Rule <FONT STYLE="white-space:nowrap">14e-1</FONT> under the Exchange Act and any other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the Notes
as a result of a Change of Control Triggering Event. To the extent that the provisions of any securities laws or regulations conflict with the Change of Control provisions of the Notes, the Company will be required to comply with the applicable
securities laws and regulations and will not be deemed to have breached its obligations under the Change of Control provisions of the Notes by virtue of such conflicts and compliance with law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Change of Control Payment Date, the Company will be required, to the extent lawful, to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accept for payment all Notes properly tendered pursuant to the Change of Control Offer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Notes or
portions of Notes properly tendered; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officers&#146;
Certificate stating the aggregate principal amount of Notes or portions of Notes being purchased. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will not
be required to make a Change of Control Offer upon the occurrence of a Change of Control Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the
Company and the third party repurchases all Notes properly tendered and not withdrawn under its offer. In addition, the Company will not repurchase any Notes if there has occurred and is continuing on the Change of Control Payment Date an event of
default under the Indenture, other than a default in the payment of the Change of Control Payment upon a Change of Control Triggering Event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the foregoing, the following definitions are applicable: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Below Investment Grade Rating Event</B>&#148; means that the Notes are rated below an Investment Grade Rating by each of the Rating
Agencies (as defined below) on any date from the date of the public notice of an arrangement that could result in a Change of Control until the end of the <FONT STYLE="white-space:nowrap">60-day</FONT> period following public notice of the
occurrence of the Change of Control (which <FONT STYLE="white-space:nowrap">60-day</FONT> period shall be extended so long as the rating of the Notes is under publicly announced consideration for possible downgrade by any of the Rating Agencies);
<I>provided</I>, <I>however</I>, that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating will not be deemed to have occurred in respect of a particular Change of Control (and thus will not be deemed
a Below Investment Grade Rating Event for purposes of the definition of Change of Control Triggering Event) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or
inform the Trustee in writing at the Company&#146;s or the Trustee&#146;s request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the applicable Change of
Control (whether or not the applicable Change of Control has occurred at the time of the Below Investment Grade Rating Event). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control</B>&#148; means the occurrence of any of the following:
(1)&nbsp;any event requiring the filing of any report under or in response to Schedule 13D or <FONT STYLE="white-space:nowrap">14D-1</FONT> pursuant to the Exchange Act disclosing beneficial ownership of either 50% or more of the Company&#146;s
common stock then outstanding or 50% or more of the Company&#146;s voting power or the Company&#146;s voting stock then outstanding; (2)&nbsp;the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or
consolidation), in one or a series of related transactions, of all or substantially all of the Company&#146;s properties or the Company&#146;s assets and the assets of its respective subsidiaries taken as a whole to one or more persons (as defined
in the Indenture) other than the Company or one of its subsidiaries; or (3)&nbsp;the first day on which a majority of the members of the Company&#146;s Board of Directors are not Continuing Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control if (1)&nbsp;the Company becomes a direct or
indirect wholly-owned subsidiary of a holding company and (2)(A) the direct or indirect holders of the voting stock of such holding company immediately following that transaction are substantially the same as the holders of the Company&#146;s voting
stock immediately prior to that transaction or (B)&nbsp;immediately following that transaction no person (other than a holding company satisfying the requirements of this sentence) is the beneficial owner, directly or indirectly, of more than 50% of
the voting stock of such holding company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control Triggering Event</B>&#148; means the occurrence of both a Change of
Control and a Below Investment Grade Rating Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Continuing Director</B>&#148; means, as of any date of determination, any
member of the Company&#146;s Board of Directors who (1)&nbsp;was a member of such Board of Directors on the date of the issuance of the Notes; or (2)&nbsp;was nominated for election or elected to such Board of Directors with the approval of a
majority of the Continuing Directors who were members of such Board of Directors at the time of such nomination or election (either by a specific vote or by approval of the Company&#146;s proxy statement in which such member was named as a nominee
for election as a director, without objection to such nomination). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Investment Grade Rating</B>&#148; means a rating equal to or
higher than Baa3 (or the equivalent) by Moody&#146;s and <FONT STYLE="white-space:nowrap">BBB-</FONT> (or the equivalent) by S&amp;P. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Moody&#146;s</B>&#148; means Moody&#146;s Investors Service, Inc., or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Rating Agencies</B>&#148; means (1)&nbsp;each of Moody&#146;s and S&amp;P; and (2)&nbsp;if any of Moody&#146;s or S&amp;P ceases to
rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the Company&#146;s control, a &#147;nationally recognized statistical rating organization&#148; within the meaning of Rule 3(a)(62) under the Exchange
Act selected by the Company (as certified by a resolution of the Company&#146;s Board of Directors) as a replacement agency for Moody&#146;s or S&amp;P, or both of them, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>S&amp;P</B>&#148; means S&amp;P Global Ratings, a division of S&amp;P Global Inc., or its successor. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Denominations; Transfer; Exchange </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess thereof. Holders of
Notes may transfer or exchange Notes in accordance with the Indenture. The Registrar may require a Holder of Notes, among other things, to furnish appropriate endorsements or transfer documents and to pay any taxes and fees required by law or
permitted by the Indenture. The Registrar need not register the transfer of or exchange any Notes selected for redemption (except, in the case of a Note to be redeemed in part, the portion of the Note not to be redeemed) or any Notes for a period of
15&nbsp;days before a selection of Notes to be redeemed or 15&nbsp;days before an interest payment date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Persons Deemed Owners </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registered Holder of this Note may be treated as the sole owner of such Note for all purposes. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) Unclaimed Money </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to
applicable abandoned property law, if money for the payment of principal or interest remains unclaimed for two years, the Trustee or Paying Agent shall pay the money back to the Company at its request unless an abandoned property law designates
another Person. After any such payment, Holders entitled to the money must look only to the Company and not to the Trustee or Paying Agent for payment. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) Discharge and Defeasance </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain conditions, the Company at any time may terminate some or all of its obligations under the Notes and the Indenture if the
Company deposits with the Trustee money or U.S. Government Obligations for the payment of principal and interest on the Notes to redemption or maturity, as the case may be. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) Amendment; Waiver </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject
to certain exceptions set forth in the Indenture, (i)&nbsp;the Indenture or the Notes may be amended with the written consent of the Holders of at least a majority in principal amount outstanding of the Notes; and (ii)&nbsp;any default or compliance
with any provision may be waived with the written consent of the Holders of a majority in principal amount of the Notes then outstanding. Subject to certain exceptions set forth in the Indenture, without the consent of any Holder of a Note, the
Company and the Trustee may amend the Indenture or the Notes to cure any ambiguity, omission, defect or inconsistency that does not materially and adversely affect the rights of any Holder of a Note, or to comply with Article&nbsp;5 of the Indenture
or to comply with requirements of the SEC in connection with the qualification of the Indenture under the TIA. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) Defaults and Remedies
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in aggregate principal amount of the Notes
may declare all the Notes to be due and payable immediately. Certain events of bankruptcy or insolvency are Events of Default which will result in the Notes being due and payable immediately upon the occurrence of such Events of Default. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of Notes may not enforce the Indenture or the Notes except as provided in the
Indenture. The Trustee may refuse to enforce the Indenture or the Notes unless it receives indemnity or security satisfactory to it. Subject to certain limitations, Holders of a majority in principal amount of the Notes may direct the Trustee in its
exercise of any trust or power. The Trustee may withhold from Holders of Notes notice of any continuing Default (except a Default in payment of principal or interest) if it determines that withholding such notice is in the interest of the Holders of
Notes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) Trustee Dealings with the Company </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain limitations imposed by the TIA, the Trustee under the Indenture, in its individual or any other capacity, may become the
owner or pledgee of Notes and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) No Recourse Against Others </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A director, officer, employee or stockholder, as such, of the Company or the Trustee shall not have any liability for any obligations of the
Company under the Notes or the Indenture or for any claim based on, in respect of or by reason of such obligations. By accepting a Note, each Holder of a Note waives and releases all such liability. The waiver and release are part of the
consideration for the issue of the Notes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) Authentication </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall not be valid until an authorized signatory of the Trustee (or an authenticating agent) manually signs the certificate of
authentication on the face of this Note. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) Abbreviations </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Customary abbreviations may be used in the name of a Holder of a Note or an assignee, such as TEN COM (=tenants in common), TEN ENT (=tenants
by the entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) Governing Law </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note
shall be governed by, and construed in accordance with, the laws of the State of New York. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s) CUSIP Numbers </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP
numbers to be printed on the Notes and has directed the Trustee to use such CUSIP numbers in notices of redemption as a convenience to Holders of Notes. No representation is made as to the accuracy of such numbers either as printed on the Notes or
as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will furnish to any Holder of a Note upon written request and without charge to
such Holder of a Note a copy of the Indenture. Requests may be made to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">One CVS Drive &#151; MC 1008 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Woonsocket, Rhode Island 02895 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Valerie Haertel </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">To assign this Note, complete the form below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I or we assign and transfer this Note to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Print or type assignee&#146;s name, address and zip code] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Insert assignee&#146;s soc. sec. or tax I.D. No.] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and irrevocably appoint ___________ as agent to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">transfer this Note on the books of CVS Health Corporation. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The agent may substitute another to act for him. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Your Signature:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sign exactly as your name appears on the face of this Note. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>d54415dex42.htm
<DESCRIPTION>EX-4.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (&#147;DTC&#148;) TO THE COMPANY OR ITS
AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO
CEDE&nbsp;&amp; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS AND UNTIL THIS GLOBAL NOTE IS EXCHANGED IN WHOLE OR IN PART FOR A GLOBAL NOTE IN
DEFINITIVE REGISTERED FORM, THIS GLOBAL NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC OR BY DTC OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH
SUCCESSOR DEPOSITARY. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS HEALTH CORPORATION </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No.&nbsp;[&#9679;]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">$[&#9679;]</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CUSIP No.&nbsp;126650 DN7 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISIN
No. US126650DN71 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1.750% Senior Note due 2030 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CVS HEALTH CORPORATION, a Delaware corporation (such corporation, and its successors and assigns under the Indenture hereinafter referred to,
being herein called the &#147;<B>Company</B>&#148;), for value received promises to pay to CEDE&nbsp;&amp; CO., or registered assigns, the principal sum of $[&#9679;] on August&nbsp;21, 2030. If such maturity date is not a Business Day, then payment
of principal will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such maturity date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest Payment Dates: February&nbsp;21 and August 21. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Record Dates: Each February&nbsp;6 and August&nbsp;6, immediately preceding each Interest Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional provisions of this Note are set forth on the reverse side of this Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Note to be duly executed. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>CVS HEALTH CORPORATION</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Note No. [</I><I></I>&#9679;<I></I><I></I><I>] of 2030 Note</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: August&nbsp;21, 2020 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRUSTEE&#146;S CERTIFICATE OF AUTHENTICATION </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE BANK OF NEW
YORK MELLON TRUST COMPANY, N.A., </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">as Trustee, certifies that this is one of the Debt Securities referred to in the Indenture. </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Note No. [</I><I></I>&#9679;<I></I><I></I><I>] of 2030 Note</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1.750% Senior Note due 2030 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note is one of a duly authorized series of Notes of the Company, designated as its 1.750% Senior Notes due 2030 (hereinafter referred to
as the &#147;<B>Notes</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Interest </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company promises to pay interest on the principal amount of this Note at the rate per annum shown above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will pay interest on the Notes semi-annually on February&nbsp;21 and August&nbsp;21 of each year, commencing February&nbsp;21,
2021. Interest on the Notes will accrue from the most recent date to which interest has been paid or provided for, or, if no interest has been paid or provided for, from August&nbsp;21, 2020. Interest will be computed on the basis of a <FONT
STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day&nbsp;months.</FONT> The Company shall pay interest on overdue principal at the rate borne by the Notes. If any interest payment date is not a Business
Day, then payment of interest will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such interest payment date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Method of Payment </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company will pay interest on the Notes (except defaulted interest) to the Persons who are registered Holders thereof at the close of business on the February&nbsp;6 and August&nbsp;6 (whether or not a Business Day) immediately preceding the interest
payment date even if the Notes are canceled after the record date and on or before the interest payment date. Holders must surrender Notes to a Paying Agent to collect principal payments. The Company will pay principal, premium, if any, and interest
in money of the United States that at the time of payment is legal tender for payment of public and private debts by wire transfer of immediately available funds to the accounts specified by the Holders, or, if no such account is specified, the
Company may pay principal and interest by check payable in such money. It may mail an interest check to a Holder&#146;s registered address. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Paying Agent and Registrar </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Initially, The Bank of New York Mellon Trust Company, N.A., a national banking association (the &#147;<B>Trustee</B>&#148;), will act as
Paying Agent and Registrar. The Company may appoint and change any Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar</FONT> without notice. The Company or any of its domestically incorporated Wholly Owned Subsidiaries may act
as Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Indenture </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company issued the Notes under an Indenture dated as of August&nbsp;15, 2006 (the &#147;<B>Indenture</B>&#148;), between the Company and
the Trustee. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. ss.ss. 77aaa-77bbbb) as in effect on the date of the Indenture (the
&#147;<B>TIA</B>&#148;). Terms defined in the Indenture and not otherwise defined herein have the respective meanings ascribed thereto in the Indenture. The Notes are subject to all such terms, and Holders of Notes are referred to the Indenture and
the TIA for a statement of those terms. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are general unsecured senior obligations of the Company initially limited to
$1,250,000,000 aggregate principal amount (subject to Section&nbsp;2.08 of the Indenture). The Company may at any time issue additional Notes under the Indenture in unlimited amounts having the same terms as and treated as a single class with the
Notes for all purposes under the Indenture and that will vote together as one class with respect to the Notes. The Indenture imposes certain limitations on the incurrence of certain additional indebtedness by the Company and certain of its
subsidiaries and the entry into certain sale and leaseback arrangements by the Company and certain of its subsidiaries. The Indenture also restricts the ability of the Company to consolidate or merge with or into, or to transfer all or substantially
all its assets to, another person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Optional Redemption </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to May&nbsp;21, 2030 (for purposes of this Note, the &#147;<B>Applicable Par Call Date</B>&#148;), the Company, at its option, may at
any time redeem all or any portion of the Notes upon not less than 10 nor more than 60 days&#146; notice at a redemption price, plus accrued and unpaid interest, if any, to, but excluding, the redemption date, equal to the greater of (i)&nbsp;100%
of the aggregate principal amount of the Notes being redeemed or (ii)&nbsp;the sum of the present values of the remaining scheduled payments of principal and interest on the Notes being redeemed that would be due if the Notes matured on the
Applicable Par Call Date (not including any portion of such payments of interest accrued to the redemption date) discounted to the redemption date on a semiannual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of
twelve <FONT STYLE="white-space:nowrap">30-day&nbsp;months)</FONT> at the applicable Treasury Yield plus 20 basis points. On or after the Applicable Par Call Date, the Company, at its option, may at any time redeem all or any portion of the Notes
upon not less than 10 nor more than 60 days&#146; notice at a redemption price equal to 100% of the aggregate principal amount of the Notes being redeemed plus accrued and unpaid interest, if any, to, but excluding, the redemption date on such
Notes. If any redemption date is not a Business Day, then payment of the redemption price and accrued and unpaid interest will be made on the next succeeding Business Day, and no interest will accrue on the amounts so payable for the period from
such redemption date to the date payment is made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Comparable Treasury Issue</B>&#148; means the United States Treasury security
selected by an Independent Investment Banker as having a maturity comparable to the remaining term of the Notes (assuming, for this purpose, that the Notes matured on the Applicable Par Call Date) that would be utilized, at the time of selection and
in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to such remaining term. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Comparable Treasury Price</B>&#148; means, with respect to any redemption date for the Notes, (i)&nbsp;the average of the applicable
Reference Treasury Dealer Quotations for such redemption date, after excluding the highest and lowest such applicable Reference Treasury Dealer Quotations, or (ii)&nbsp;if the Independent Investment Banker obtains fewer than four such Reference
Treasury Dealer Quotations, the average of all such Reference Treasury Dealer Quotations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Independent Investment Banker</B>&#148; means Barclays Capital Inc. or, if such
firm is unwilling or unable to select the applicable Comparable Treasury Issue, an independent investment banking institution of national standing appointed by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Reference Treasury Dealer</B>&#148; means (i)&nbsp;Barclays Capital Inc., BofA Securities, Inc. and Goldman Sachs&nbsp;&amp; Co. LLC
and their respective successors; <I>provided</I>, <I>however</I>, that if any of the foregoing shall cease to be a primary United States government securities dealer in New York City (a &#147;<B>Primary Treasury Dealer</B>&#148;), the Company shall
substitute therefor another Primary Treasury Dealer and (ii)&nbsp;any other Primary Treasury Dealer selected by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Reference Treasury Dealer Quotations</B>&#148; means, with respect to each Reference Treasury Dealer and any redemption date for the
Notes, the average, as determined by the Independent Investment Banker, of the bid and asked prices for the Comparable Treasury Issue for the Notes (expressed as a percentage of the aggregate principal amount of the Comparable Treasury Issue) quoted
in writing to the Independent Investment Banker by such Reference Treasury Dealer at 5:00&nbsp;p.m., New York City time, on the third business day preceding such redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Treasury Yield</B>&#148; means, with respect to any redemption date for the Notes, the rate per annum equal to the semiannual
equivalent yield to maturity of the Comparable Treasury Issue for the Notes, assuming a price for the Comparable Treasury Issue (expressed as a percentage of the aggregate principal amount of the Comparable Treasury Issue) equal to the applicable
Comparable Treasury Price for such redemption date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Notice of Optional Redemption </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of redemption shall be transmitted by the Company (or, at the Company&#146;s request, by the Trustee on the Company&#146;s behalf) to
each Holder of Notes to be redeemed. Notes in denominations larger than $2,000 may be redeemed in part but only in whole multiples of $1,000. If money sufficient to pay the redemption price of and accrued interest on all Notes (or portions thereof)
to be redeemed on the redemption date is deposited with the Paying Agent on or before the redemption date and certain other conditions are satisfied, on and after such date interest ceases to accrue on such Notes (or such portions thereof) called
for redemption. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Repurchase of the Notes Upon a Change of Control Triggering Event </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a Change of Control Triggering Event (as defined below) occurs, Holders of the Notes will have the right to require the Company to
repurchase all or any part (in integral multiples of $1,000 up to the original principal amount) of their Notes pursuant to the offer described below (the &#147;<B>Change of Control Offer</B>&#148;) on the terms set forth in this Note. In the Change
of Control Offer, the Company will be required to offer payment in cash equal to 101% of the aggregate principal amount of Notes repurchased plus accrued and unpaid interest, if any, on the Notes repurchased, to, but excluding, the date of purchase
(the &#147;<B>Change of Control Payment</B>&#148;). Within 30 days following any Change of Control Triggering Event, the Company will be required to mail a notice to Holders of Notes describing the transaction or transactions that constitute the
Change of Control Triggering Event and offering to repurchase the Notes on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
notice is mailed (the &#147;<B>Change of Control Payment Date</B>&#148;), pursuant to the procedures required by this Note and described in such notice. The Company must comply with the
requirements of Rule <FONT STYLE="white-space:nowrap">14e-1</FONT> under the Exchange Act and any other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the Notes
as a result of a Change of Control Triggering Event. To the extent that the provisions of any securities laws or regulations conflict with the Change of Control provisions of the Notes, the Company will be required to comply with the applicable
securities laws and regulations and will not be deemed to have breached its obligations under the Change of Control provisions of the Notes by virtue of such conflicts and compliance with law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Change of Control Payment Date, the Company will be required, to the extent lawful, to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accept for payment all Notes properly tendered pursuant to the Change of Control Offer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Notes or
portions of Notes properly tendered; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officers&#146;
Certificate stating the aggregate principal amount of Notes or portions of Notes being purchased. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will not
be required to make a Change of Control Offer upon the occurrence of a Change of Control Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the
Company and the third party repurchases all Notes properly tendered and not withdrawn under its offer. In addition, the Company will not repurchase any Notes if there has occurred and is continuing on the Change of Control Payment Date an event of
default under the Indenture, other than a default in the payment of the Change of Control Payment upon a Change of Control Triggering Event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the foregoing, the following definitions are applicable: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Below Investment Grade Rating Event</B>&#148; means that the Notes are rated below an Investment Grade Rating by each of the Rating
Agencies (as defined below) on any date from the date of the public notice of an arrangement that could result in a Change of Control until the end of the <FONT STYLE="white-space:nowrap">60-day</FONT> period following public notice of the
occurrence of the Change of Control (which <FONT STYLE="white-space:nowrap">60-day</FONT> period shall be extended so long as the rating of the Notes is under publicly announced consideration for possible downgrade by any of the Rating Agencies);
<I>provided</I>, <I>however</I>, that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating will not be deemed to have occurred in respect of a particular Change of Control (and thus will not be deemed
a Below Investment Grade Rating Event for purposes of the definition of Change of Control Triggering Event) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or
inform the Trustee in writing at the Company&#146;s or the Trustee&#146;s request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the applicable Change of
Control (whether or not the applicable Change of Control has occurred at the time of the Below Investment Grade Rating Event). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control</B>&#148; means the occurrence of any of the following:
(1)&nbsp;any event requiring the filing of any report under or in response to Schedule 13D or <FONT STYLE="white-space:nowrap">14D-1</FONT> pursuant to the Exchange Act disclosing beneficial ownership of either 50% or more of the Company&#146;s
common stock then outstanding or 50% or more of the Company&#146;s voting power or the Company&#146;s voting stock then outstanding; (2)&nbsp;the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or
consolidation), in one or a series of related transactions, of all or substantially all of the Company&#146;s properties or the Company&#146;s assets and the assets of its respective subsidiaries taken as a whole to one or more persons (as defined
in the Indenture) other than the Company or one of its subsidiaries; or (3)&nbsp;the first day on which a majority of the members of the Company&#146;s Board of Directors are not Continuing Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control if (1)&nbsp;the Company becomes a direct or
indirect wholly-owned subsidiary of a holding company and (2)(A) the direct or indirect holders of the voting stock of such holding company immediately following that transaction are substantially the same as the holders of the Company&#146;s voting
stock immediately prior to that transaction or (B)&nbsp;immediately following that transaction no person (other than a holding company satisfying the requirements of this sentence) is the beneficial owner, directly or indirectly, of more than 50% of
the voting stock of such holding company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control Triggering Event</B>&#148; means the occurrence of both a Change of
Control and a Below Investment Grade Rating Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Continuing Director</B>&#148; means, as of any date of determination, any
member of the Company&#146;s Board of Directors who (1)&nbsp;was a member of such Board of Directors on the date of the issuance of the Notes; or (2)&nbsp;was nominated for election or elected to such Board of Directors with the approval of a
majority of the Continuing Directors who were members of such Board of Directors at the time of such nomination or election (either by a specific vote or by approval of the Company&#146;s proxy statement in which such member was named as a nominee
for election as a director, without objection to such nomination). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Investment Grade Rating</B>&#148; means a rating equal to or
higher than Baa3 (or the equivalent) by Moody&#146;s and <FONT STYLE="white-space:nowrap">BBB-</FONT> (or the equivalent) by S&amp;P. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Moody&#146;s</B>&#148; means Moody&#146;s Investors Service, Inc., or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Rating Agencies</B>&#148; means (1)&nbsp;each of Moody&#146;s and S&amp;P; and (2)&nbsp;if any of Moody&#146;s or S&amp;P ceases to
rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the Company&#146;s control, a &#147;nationally recognized statistical rating organization&#148; within the meaning of Rule 3(a)(62) under the Exchange
Act selected by the Company (as certified by a resolution of the Company&#146;s Board of Directors) as a replacement agency for Moody&#146;s or S&amp;P, or both of them, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>S&amp;P</B>&#148; means S&amp;P Global Ratings, a division of S&amp;P Global Inc., or its successor. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Denominations; Transfer; Exchange </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess thereof. Holders of
Notes may transfer or exchange Notes in accordance with the Indenture. The Registrar may require a Holder of Notes, among other things, to furnish appropriate endorsements or transfer documents and to pay any taxes and fees required by law or
permitted by the Indenture. The Registrar need not register the transfer of or exchange any Notes selected for redemption (except, in the case of a Note to be redeemed in part, the portion of the Note not to be redeemed) or any Notes for a period of
15&nbsp;days before a selection of Notes to be redeemed or 15&nbsp;days before an interest payment date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Persons Deemed Owners </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registered Holder of this Note may be treated as the sole owner of such Note for all purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) Unclaimed Money </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to
applicable abandoned property law, if money for the payment of principal or interest remains unclaimed for two years, the Trustee or Paying Agent shall pay the money back to the Company at its request unless an abandoned property law designates
another Person. After any such payment, Holders entitled to the money must look only to the Company and not to the Trustee or Paying Agent for payment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) Discharge and Defeasance </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain conditions, the Company at any time may terminate some or all of its obligations under the Notes and the Indenture if the
Company deposits with the Trustee money or U.S. Government Obligations for the payment of principal and interest on the Notes to redemption or maturity, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) Amendment; Waiver </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject
to certain exceptions set forth in the Indenture, (i)&nbsp;the Indenture or the Notes may be amended with the written consent of the Holders of at least a majority in principal amount outstanding of the Notes; and (ii)&nbsp;any default or compliance
with any provision may be waived with the written consent of the Holders of a majority in principal amount of the Notes then outstanding. Subject to certain exceptions set forth in the Indenture, without the consent of any Holder of a Note, the
Company and the Trustee may amend the Indenture or the Notes to cure any ambiguity, omission, defect or inconsistency that does not materially and adversely affect the rights of any Holder of a Note, or to comply with Article&nbsp;5 of the Indenture
or to comply with requirements of the SEC in connection with the qualification of the Indenture under the TIA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) Defaults and Remedies
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in aggregate principal amount of the Notes
may declare all the Notes to be due and payable immediately. Certain events of bankruptcy or insolvency are Events of Default which will result in the Notes being due and payable immediately upon the occurrence of such Events of Default. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of Notes may not enforce the Indenture or the Notes except as provided in the
Indenture. The Trustee may refuse to enforce the Indenture or the Notes unless it receives indemnity or security satisfactory to it. Subject to certain limitations, Holders of a majority in principal amount of the Notes may direct the Trustee in its
exercise of any trust or power. The Trustee may withhold from Holders of Notes notice of any continuing Default (except a Default in payment of principal or interest) if it determines that withholding such notice is in the interest of the Holders of
Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) Trustee Dealings with the Company </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain limitations imposed by the TIA, the Trustee under the Indenture, in its individual or any other capacity, may become the
owner or pledgee of Notes and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) No Recourse Against Others </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A director, officer, employee or stockholder, as such, of the Company or the Trustee shall not have any liability for any obligations of the
Company under the Notes or the Indenture or for any claim based on, in respect of or by reason of such obligations. By accepting a Note, each Holder of a Note waives and releases all such liability. The waiver and release are part of the
consideration for the issue of the Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) Authentication </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall not be valid until an authorized signatory of the Trustee (or an authenticating agent) manually signs the certificate of
authentication on the face of this Note. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) Abbreviations </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Customary abbreviations may be used in the name of a Holder of a Note or an assignee, such as TEN COM (=tenants in common), TEN ENT (=tenants
by the entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) Governing Law </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note
shall be governed by, and construed in accordance with, the laws of the State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s) CUSIP Numbers </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP
numbers to be printed on the Notes and has directed the Trustee to use such CUSIP numbers in notices of redemption as a convenience to Holders of Notes. No representation is made as to the accuracy of such numbers either as printed on the Notes or
as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will furnish to any Holder of a Note upon written request and without charge to
such Holder of a Note a copy of the Indenture. Requests may be made to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">One CVS Drive &#151; MC 1008 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Woonsocket, Rhode Island 02895 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Valerie Haertel </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">To assign this Note, complete the form below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I or we assign and transfer this Note to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Print or type assignee&#146;s name, address and zip code] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Insert assignee&#146;s soc. sec. or tax I.D. No.] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:32%; font-size:10pt; font-family:Times New Roman">and irrevocably appoint ___________ as agent to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:32%; font-size:10pt; font-family:Times New Roman">transfer this Note on the books of CVS Health Corporation. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:32%; font-size:10pt; font-family:Times New Roman">The agent may substitute another to act for him. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Your&nbsp;Signature:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sign exactly as your name appears on the face of this Note. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>4
<FILENAME>d54415dex43.htm
<DESCRIPTION>EX-4.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (&#147;DTC&#148;) TO THE COMPANY OR ITS
AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO
CEDE&nbsp;&amp; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS AND UNTIL THIS GLOBAL NOTE IS EXCHANGED IN WHOLE OR IN PART FOR A GLOBAL NOTE IN
DEFINITIVE REGISTERED FORM, THIS GLOBAL NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC OR BY DTC OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH
SUCCESSOR DEPOSITARY. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS HEALTH CORPORATION </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">No.&nbsp;[&#149;]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">$[&#149;]</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CUSIP No.&nbsp;126650 DP2 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISIN
No. US126650DP20 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2.700% Senior Note due 2040 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CVS HEALTH CORPORATION, a Delaware corporation (such corporation, and its successors and assigns under the Indenture hereinafter referred to,
being herein called the &#147;<B>Company</B>&#148;), for value received promises to pay to CEDE&nbsp;&amp; CO., or registered assigns, the principal sum of $[&#149;] on August&nbsp;21, 2040. If such maturity date is not a Business Day, then payment
of principal will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such maturity date to the date payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest Payment Dates: February&nbsp;21 and August 21. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Record Dates: Each February&nbsp;6 and August&nbsp;6, immediately preceding each Interest Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional provisions of this Note are set forth on the reverse side of this Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Note to be duly executed. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CVS HEALTH CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Note No. [</I><I></I>&#9679;<I></I><I></I><I>] of 2040 Note</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: August&nbsp;21, 2020 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRUSTEE&#146;S CERTIFICATE OF AUTHENTICATION </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE BANK OF NEW
YORK MELLON TRUST COMPANY, N.A., </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">as Trustee, certifies that this is one of the Debt Securities referred to in the Indenture.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Note No. [</I><I></I>&#9679;<I></I><I></I><I>] of 2040 Note</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2.700% Senior Note due 2040 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note is one of a duly authorized series of Notes of the Company, designated as its 2.700% Senior Notes due 2040 (hereinafter referred to
as the &#147;<B>Notes</B>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Interest </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company promises to pay interest on the principal amount of this Note at the rate per annum shown above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will pay interest on the Notes semi-annually on February&nbsp;21 and August&nbsp;21 of each year, commencing February&nbsp;21,
2021. Interest on the Notes will accrue from the most recent date to which interest has been paid or provided for, or, if no interest has been paid or provided for, from August&nbsp;21, 2020. Interest will be computed on the basis of a <FONT
STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day&nbsp;months.</FONT> The Company shall pay interest on overdue principal at the rate borne by the Notes. If any interest payment date is not a Business
Day, then payment of interest will be made on the next succeeding Business Day and no interest will accrue on the amount so payable for the period from such interest payment date to the date payment is made. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) Method of Payment </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company will pay interest on the Notes (except defaulted interest) to the Persons who are registered Holders thereof at the close of business on the February&nbsp;6 and August&nbsp;6 (whether or not a Business Day) immediately preceding the interest
payment date even if the Notes are canceled after the record date and on or before the interest payment date. Holders must surrender Notes to a Paying Agent to collect principal payments. The Company will pay principal, premium, if any, and interest
in money of the United States that at the time of payment is legal tender for payment of public and private debts by wire transfer of immediately available funds to the accounts specified by the Holders, or, if no such account is specified, the
Company may pay principal and interest by check payable in such money. It may mail an interest check to a Holder&#146;s registered address. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Paying Agent and Registrar </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Initially, The Bank of New York Mellon Trust Company, N.A., a national banking association (the &#147;<B>Trustee</B>&#148;), will act as
Paying Agent and Registrar. The Company may appoint and change any Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar</FONT> without notice. The Company or any of its domestically incorporated Wholly Owned Subsidiaries may act
as Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar.</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Indenture </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company issued the Notes under an Indenture dated as of August&nbsp;15, 2006 (the &#147;<B>Indenture</B>&#148;), between the Company and
the Trustee. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. ss.ss. 77aaa-77bbbb) as in effect on the date of the Indenture (the
&#147;<B>TIA</B>&#148;). Terms defined in the Indenture and not otherwise defined herein have the respective meanings ascribed thereto in the Indenture. The Notes are subject to all such terms, and Holders of Notes are referred to the Indenture and
the TIA for a statement of those terms. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are general unsecured senior obligations of the Company initially limited to
$1,250,000,000 aggregate principal amount (subject to Section&nbsp;2.08 of the Indenture). The Company may at any time issue additional Notes under the Indenture in unlimited amounts having the same terms as and treated as a single class with the
Notes for all purposes under the Indenture and that will vote together as one class with respect to the Notes. The Indenture imposes certain limitations on the incurrence of certain additional indebtedness by the Company and certain of its
subsidiaries and the entry into certain sale and leaseback arrangements by the Company and certain of its subsidiaries. The Indenture also restricts the ability of the Company to consolidate or merge with or into, or to transfer all or substantially
all its assets to, another person. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Optional Redemption </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to February&nbsp;21, 2040 (for purposes of this Note, the &#147;<B>Applicable Par Call Date</B>&#148;), the Company, at its option, may
at any time redeem all or any portion of the Notes upon not less than 10 nor more than 60 days&#146; notice at a redemption price, plus accrued and unpaid interest, if any, to, but excluding, the redemption date, equal to the greater of
(i)&nbsp;100% of the aggregate principal amount of the Notes being redeemed or (ii)&nbsp;the sum of the present values of the remaining scheduled payments of principal and interest on the Notes being redeemed that would be due if the Notes matured
on the Applicable Par Call Date (not including any portion of such payments of interest accrued to the redemption date) discounted to the redemption date on a semiannual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year
consisting of twelve <FONT STYLE="white-space:nowrap">30-day&nbsp;months)</FONT> at the applicable Treasury Yield plus 25 basis points. On or after the Applicable Par Call Date, the Company, at its option, may at any time redeem all or any portion
of the Notes upon not less than 10 nor more than 60 days&#146; notice at a redemption price equal to 100% of the aggregate principal amount of the Notes being redeemed plus accrued and unpaid interest, if any, to, but excluding, the redemption date
on such Notes. If any redemption date is not a Business Day, then payment of the redemption price and accrued and unpaid interest will be made on the next succeeding Business Day, and no interest will accrue on the amounts so payable for the period
from such redemption date to the date payment is made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Comparable Treasury Issue</B>&#148; means the United States Treasury
security selected by an Independent Investment Banker as having a maturity comparable to the remaining term of the Notes (assuming, for this purpose, that the Notes matured on the Applicable Par Call Date) that would be utilized, at the time of
selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to such remaining term. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Comparable Treasury Price</B>&#148; means, with respect to any redemption date for the Notes, (i)&nbsp;the average of the applicable
Reference Treasury Dealer Quotations for such redemption date, after excluding the highest and lowest such applicable Reference Treasury Dealer Quotations, or (ii)&nbsp;if the Independent Investment Banker obtains fewer than four such Reference
Treasury Dealer Quotations, the average of all such Reference Treasury Dealer Quotations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Independent Investment Banker</B>&#148; means Barclays Capital Inc. or, if such
firm is unwilling or unable to select the applicable Comparable Treasury Issue, an independent investment banking institution of national standing appointed by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Reference Treasury Dealer</B>&#148; means (i)&nbsp;Barclays Capital Inc., BofA Securities, Inc. and Goldman Sachs&nbsp;&amp; Co. LLC
and their respective successors; <I>provided</I>, <I>however</I>, that if any of the foregoing shall cease to be a primary United States government securities dealer in New York City (a &#147;<B>Primary Treasury Dealer</B>&#148;), the Company shall
substitute therefor another Primary Treasury Dealer and (ii)&nbsp;any other Primary Treasury Dealer selected by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Reference Treasury Dealer Quotations</B>&#148; means, with respect to each Reference Treasury Dealer and any redemption date for the
Notes, the average, as determined by the Independent Investment Banker, of the bid and asked prices for the Comparable Treasury Issue for the Notes (expressed as a percentage of the aggregate principal amount of the Comparable Treasury Issue) quoted
in writing to the Independent Investment Banker by such Reference Treasury Dealer at 5:00&nbsp;p.m., New York City time, on the third business day preceding such redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Treasury Yield</B>&#148; means, with respect to any redemption date for the Notes, the rate per annum equal to the semiannual
equivalent yield to maturity of the Comparable Treasury Issue for the Notes, assuming a price for the Comparable Treasury Issue (expressed as a percentage of the aggregate principal amount of the Comparable Treasury Issue) equal to the applicable
Comparable Treasury Price for such redemption date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Notice of Optional Redemption </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of redemption shall be transmitted by the Company (or, at the Company&#146;s request, by the Trustee on the Company&#146;s behalf) to
each Holder of Notes to be redeemed. Notes in denominations larger than $2,000 may be redeemed in part but only in whole multiples of $1,000. If money sufficient to pay the redemption price of and accrued interest on all Notes (or portions thereof)
to be redeemed on the redemption date is deposited with the Paying Agent on or before the redemption date and certain other conditions are satisfied, on and after such date interest ceases to accrue on such Notes (or such portions thereof) called
for redemption. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Repurchase of the Notes Upon a Change of Control Triggering Event </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a Change of Control Triggering Event (as defined below) occurs, Holders of the Notes will have the right to require the Company to
repurchase all or any part (in integral multiples of $1,000 up to the original principal amount) of their Notes pursuant to the offer described below (the &#147;<B>Change of Control Offer</B>&#148;) on the terms set forth in this Note. In the Change
of Control Offer, the Company will be required to offer payment in cash equal to 101% of the aggregate principal amount of Notes repurchased plus accrued and unpaid interest, if any, on the Notes repurchased, to, but excluding, the date of purchase
(the &#147;<B>Change of Control Payment</B>&#148;). Within 30 days following any Change of Control Triggering Event, the Company will be required to mail a notice to Holders of Notes describing the transaction or transactions that constitute the
Change of Control Triggering Event and offering to repurchase the Notes on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
notice is mailed (the &#147;<B>Change of Control Payment Date</B>&#148;), pursuant to the procedures required by this Note and described in such notice. The Company must comply with the
requirements of Rule <FONT STYLE="white-space:nowrap">14e-1</FONT> under the Exchange Act and any other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the Notes
as a result of a Change of Control Triggering Event. To the extent that the provisions of any securities laws or regulations conflict with the Change of Control provisions of the Notes, the Company will be required to comply with the applicable
securities laws and regulations and will not be deemed to have breached its obligations under the Change of Control provisions of the Notes by virtue of such conflicts and compliance with law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Change of Control Payment Date, the Company will be required, to the extent lawful, to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">accept for payment all Notes properly tendered pursuant to the Change of Control Offer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Notes or
portions of Notes properly tendered; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officers&#146;
Certificate stating the aggregate principal amount of Notes or portions of Notes being purchased. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will not
be required to make a Change of Control Offer upon the occurrence of a Change of Control Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the
Company and the third party repurchases all Notes properly tendered and not withdrawn under its offer. In addition, the Company will not repurchase any Notes if there has occurred and is continuing on the Change of Control Payment Date an event of
default under the Indenture, other than a default in the payment of the Change of Control Payment upon a Change of Control Triggering Event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the foregoing, the following definitions are applicable: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Below Investment Grade Rating Event</B>&#148; means that the Notes are rated below an Investment Grade Rating by each of the Rating
Agencies (as defined below) on any date from the date of the public notice of an arrangement that could result in a Change of Control until the end of the <FONT STYLE="white-space:nowrap">60-day</FONT> period following public notice of the
occurrence of the Change of Control (which <FONT STYLE="white-space:nowrap">60-day</FONT> period shall be extended so long as the rating of the Notes is under publicly announced consideration for possible downgrade by any of the Rating Agencies);
<I>provided</I>, <I>however</I>, that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating will not be deemed to have occurred in respect of a particular Change of Control (and thus will not be deemed
a Below Investment Grade Rating Event for purposes of the definition of Change of Control Triggering Event) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or
inform the Trustee in writing at the Company&#146;s or the Trustee&#146;s request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the applicable Change of
Control (whether or not the applicable Change of Control has occurred at the time of the Below Investment Grade Rating Event). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control</B>&#148; means the occurrence of any of the following:
(1)&nbsp;any event requiring the filing of any report under or in response to Schedule 13D or <FONT STYLE="white-space:nowrap">14D-1</FONT> pursuant to the Exchange Act disclosing beneficial ownership of either 50% or more of the Company&#146;s
common stock then outstanding or 50% or more of the Company&#146;s voting power or the Company&#146;s voting stock then outstanding; (2)&nbsp;the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or
consolidation), in one or a series of related transactions, of all or substantially all of the Company&#146;s properties or the Company&#146;s assets and the assets of its respective subsidiaries taken as a whole to one or more persons (as defined
in the Indenture) other than the Company or one of its subsidiaries; or (3)&nbsp;the first day on which a majority of the members of the Company&#146;s Board of Directors are not Continuing Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control if (1)&nbsp;the Company becomes a direct or
indirect wholly-owned subsidiary of a holding company and (2)(A) the direct or indirect holders of the voting stock of such holding company immediately following that transaction are substantially the same as the holders of the Company&#146;s voting
stock immediately prior to that transaction or (B)&nbsp;immediately following that transaction no person (other than a holding company satisfying the requirements of this sentence) is the beneficial owner, directly or indirectly, of more than 50% of
the voting stock of such holding company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change of Control Triggering Event</B>&#148; means the occurrence of both a Change of
Control and a Below Investment Grade Rating Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Continuing Director</B>&#148; means, as of any date of determination, any
member of the Company&#146;s Board of Directors who (1)&nbsp;was a member of such Board of Directors on the date of the issuance of the Notes; or (2)&nbsp;was nominated for election or elected to such Board of Directors with the approval of a
majority of the Continuing Directors who were members of such Board of Directors at the time of such nomination or election (either by a specific vote or by approval of the Company&#146;s proxy statement in which such member was named as a nominee
for election as a director, without objection to such nomination). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Investment Grade Rating</B>&#148; means a rating equal to or
higher than Baa3 (or the equivalent) by Moody&#146;s and <FONT STYLE="white-space:nowrap">BBB-</FONT> (or the equivalent) by S&amp;P. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Moody&#146;s</B>&#148; means Moody&#146;s Investors Service, Inc., or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Rating Agencies</B>&#148; means (1)&nbsp;each of Moody&#146;s and S&amp;P; and (2)&nbsp;if any of Moody&#146;s or S&amp;P ceases to
rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the Company&#146;s control, a &#147;nationally recognized statistical rating organization&#148; within the meaning of Rule 3(a)(62) under the Exchange
Act selected by the Company (as certified by a resolution of the Company&#146;s Board of Directors) as a replacement agency for Moody&#146;s or S&amp;P, or both of them, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>S&amp;P</B>&#148; means S&amp;P Global Ratings, a division of S&amp;P Global Inc., or its successor. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Denominations; Transfer; Exchange </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess thereof. Holders of
Notes may transfer or exchange Notes in accordance with the Indenture. The Registrar may require a Holder of Notes, among other things, to furnish appropriate endorsements or transfer documents and to pay any taxes and fees required by law or
permitted by the Indenture. The Registrar need not register the transfer of or exchange any Notes selected for redemption (except, in the case of a Note to be redeemed in part, the portion of the Note not to be redeemed) or any Notes for a period of
15&nbsp;days before a selection of Notes to be redeemed or 15&nbsp;days before an interest payment date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Persons Deemed Owners </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registered Holder of this Note may be treated as the sole owner of such Note for all purposes. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) Unclaimed Money </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to
applicable abandoned property law, if money for the payment of principal or interest remains unclaimed for two years, the Trustee or Paying Agent shall pay the money back to the Company at its request unless an abandoned property law designates
another Person. After any such payment, Holders entitled to the money must look only to the Company and not to the Trustee or Paying Agent for payment. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) Discharge and Defeasance </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain conditions, the Company at any time may terminate some or all of its obligations under the Notes and the Indenture if the
Company deposits with the Trustee money or U.S. Government Obligations for the payment of principal and interest on the Notes to redemption or maturity, as the case may be. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) Amendment; Waiver </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject
to certain exceptions set forth in the Indenture, (i)&nbsp;the Indenture or the Notes may be amended with the written consent of the Holders of at least a majority in principal amount outstanding of the Notes; and (ii)&nbsp;any default or compliance
with any provision may be waived with the written consent of the Holders of a majority in principal amount of the Notes then outstanding. Subject to certain exceptions set forth in the Indenture, without the consent of any Holder of a Note, the
Company and the Trustee may amend the Indenture or the Notes to cure any ambiguity, omission, defect or inconsistency that does not materially and adversely affect the rights of any Holder of a Note, or to comply with Article&nbsp;5 of the Indenture
or to comply with requirements of the SEC in connection with the qualification of the Indenture under the TIA. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(m) Defaults and Remedies
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an Event of Default occurs and is continuing, the Trustee or the Holders of at least 25%
in aggregate principal amount of the Notes may declare all the Notes to be due and payable immediately. Certain events of bankruptcy or insolvency are Events of Default which will result in the Notes being due and payable immediately upon the
occurrence of such Events of Default. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of Notes may not enforce the Indenture or the Notes except as provided in the Indenture.
The Trustee may refuse to enforce the Indenture or the Notes unless it receives indemnity or security satisfactory to it. Subject to certain limitations, Holders of a majority in principal amount of the Notes may direct the Trustee in its exercise
of any trust or power. The Trustee may withhold from Holders of Notes notice of any continuing Default (except a Default in payment of principal or interest) if it determines that withholding such notice is in the interest of the Holders of Notes.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) Trustee Dealings with the Company </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain limitations imposed by the TIA, the Trustee under the Indenture, in its individual or any other capacity, may become the
owner or pledgee of Notes and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) No Recourse Against Others </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A director, officer, employee or stockholder, as such, of the Company or the Trustee shall not have any liability for any obligations of the
Company under the Notes or the Indenture or for any claim based on, in respect of or by reason of such obligations. By accepting a Note, each Holder of a Note waives and releases all such liability. The waiver and release are part of the
consideration for the issue of the Notes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) Authentication </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall not be valid until an authorized signatory of the Trustee (or an authenticating agent) manually signs the certificate of
authentication on the face of this Note. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) Abbreviations </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Customary abbreviations may be used in the name of a Holder of a Note or an assignee, such as TEN COM (=tenants in common), TEN ENT (=tenants
by the entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) Governing Law </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note
shall be governed by, and construed in accordance with, the laws of the State of New York. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s) CUSIP Numbers </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP
numbers to be printed on the Notes and has directed the Trustee to use such CUSIP numbers in notices of redemption as a convenience to Holders of Notes. No representation is made as to the accuracy of such numbers either as printed on the Notes or
as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will furnish to any Holder of a Note upon written request and without charge to
such Holder of a Note a copy of the Indenture. Requests may be made to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">One CVS Drive &#151; MC 1008 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Woonsocket, Rhode Island 02895 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Valerie Haertel </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">To assign this Note, complete the form below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I or we assign and transfer this Note to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Print or type assignee&#146;s name, address and zip code] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Insert assignee&#146;s soc. sec. or tax I.D. No.] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:32%; font-size:10pt; font-family:Times New Roman">and irrevocably appoint ___________ as agent to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:32%; font-size:10pt; font-family:Times New Roman">transfer this Note on the books of CVS Health Corporation. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:32%; font-size:10pt; font-family:Times New Roman">The agent may substitute another to act for him. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:&nbsp;&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Your Signature: &nbsp;&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sign exactly as your name appears on the face of this Note. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>5
<FILENAME>d54415dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g5441546.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">599 Lexington Avenue </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">New York, NY 10022-6069 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">+1.212.848.4000 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">August&nbsp;21,
2020 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CVS Health Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One CVS Drive </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Woonsocket, RI 02895 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CVS Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>$1,500,000,000 1.300% Senior Notes due 2027 </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>$1,250,000,000 1.750% Senior Notes due 2030 </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>$1,250,000,000 2.700% Senior Notes due 2040 </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have acted as counsel to CVS Health
Corporation, a Delaware corporation (the &#147;<U>Company</U>&#148;), in connection with the issuance and sale by the Company of $1,500,000,000 aggregate principal amount of the Company&#146;s 1.300% Senior Notes due 2027 (the &#147;<U>2027
Notes</U>&#148;), $1,250,000,000 aggregate principal amount of the Company&#146;s 1.750% Senior Notes due 2030 (the &#147;<U>2030 Notes</U>&#148;) and $1,250,000,000 aggregate principal amount of the Company&#146;s 2.700% Senior Notes due 2040 (the
&#147;<U>2040 Notes</U>&#148; and, together with the 2027 Notes and the 2030 Notes, the &#147;<U>Notes</U>&#148;) pursuant to the Underwriting Agreement, dated August&nbsp;12, 2020 (the &#147;<U>Underwriting Agreement</U>&#148;), among the Company
and the underwriters named therein. The Notes will be issued pursuant to an indenture, dated as of August&nbsp;15, 2006 (the &#147;<U>Indenture</U>&#148;), between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the
&#147;<U>Trustee</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In that connection, we have reviewed originals or copies of the following documents: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Underwriting Agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Indenture; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Executive Officers&#146; Certificate pursuant to the Indenture dated August&nbsp;21, 2020; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Notes in global form as executed by the Company. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The documents described in the foregoing clauses (a)&nbsp;through (d) are collectively referred to herein as the &#147;<U>Opinion Documents</U>&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In our review of the Opinion Documents, we have assumed: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The genuineness of all signatures. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The authenticity of the originals of the documents submitted to us. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The conformity to authentic originals of any documents submitted to us as copies. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SHEARMAN.COM </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Shearman&nbsp;&amp; Sterling LLP is a
limited liability partnership organized in the United States under the laws of the state of Delaware, which laws limit the personal liability of partners. </P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As to matters of fact, the truthfulness of the representations made in the Underwriting Agreement and the other
Opinion Documents and in certificates of public officials and officers of the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That each of the Opinion Documents is the legal, valid and binding obligation of each party thereto, other than
the Company, enforceable against each such party in accordance with its terms. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That the execution, delivery and performance by the Company of the Opinion Documents to which it is a party do
not and will not, except with respect to Generally Applicable Law, violate any law, rule or regulation applicable to it. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That the execution, delivery and performance by the Company of the Opinion Documents to which it is a party do
not and will not result in any conflict with or breach of any agreement or document binding on it. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That, except with respect to Generally Applicable Law, no authorization, approval, consent or other action by,
and no notice to or filing with, any governmental authority or regulatory body or any other third party is required for the due execution, delivery or performance by the Company of any Opinion Document to which it is a party or, if any such
authorization, approval, consent, action, notice or filing is required, it has been duly obtained, taken, given or made and is in full force and effect. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have not independently established the validity of the foregoing assumptions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Generally Applicable Law</U>&#148; means the federal law of the United States of America, and the law of the State of New&nbsp;York (including in
each case the rules or regulations promulgated thereunder or pursuant thereto), that a New&nbsp;York lawyer exercising customary professional diligence would reasonably be expected to recognize as being applicable to the Company, the Opinion
Documents or the transactions governed by the Opinion Documents, and for purposes of assumption paragraphs (f)&nbsp;and (h) above and our opinion below, the General Corporation Law of the State of Delaware. Without limiting the generality of the
foregoing definition of Generally Applicable Law, the term &#147;Generally Applicable Law&#148; does not include any law, rule or regulation that is applicable to the Company, the Opinion Documents or such transactions solely because such law, rule
or regulation is part of a regulatory regime applicable to any party to any of the Opinion Documents or any of its affiliates due to the specific assets or business of such party or such affiliate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based upon the foregoing and upon such other investigation as we have deemed necessary and subject to the qualifications set forth below, we are of the
opinion that the Notes have been duly authorized and executed by the Company and, when authenticated by the Trustee in accordance with the Indenture and delivered and paid for as provided in the Underwriting Agreement, the Notes will be the legal,
valid and binding obligations of the Company, enforceable against the Company in accordance with their terms and entitled to the benefits of the Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our opinion expressed above is subject to the following qualifications: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Our opinion above is subject to the effect of any applicable bankruptcy, insolvency, reorganization, moratorium
or similar laws affecting creditors&#146; rights generally (including without limitation all laws relating to fraudulent transfers). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Our opinion above is also subject to the effect of general principles of equity, including without limitation
concepts of materiality, reasonableness, good faith and fair dealing (regardless of whether considered in a proceeding in equity or at law). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Our opinion is limited to Generally Applicable Law, and we do not express any opinion herein concerning any
other law. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This opinion letter speaks only as of the date hereof. We expressly disclaim any responsibility to advise you of any
development or circumstance of any kind, including any change of law or fact, that may occur after the date of this opinion letter and which might affect the opinions expressed herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This opinion letter is rendered to you in connection with the transactions contemplated by the Opinion Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this opinion as an exhibit to the Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> to be filed
August&nbsp;21, 2020 by the Company and incorporated by reference into the Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3ASR</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-238506)</FONT> filed by the Company to
effect the registration of the Notes under the Securities Act of 1933, as amended (the &#147;<U>Securities Act</U>&#148;), and to the use of our name under the heading &#147;Legal Matters&#148; in the prospectus constituting a part of such
Registration Statement. In giving such consent, we do not hereby admit that we are in the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules and regulations of the Securities and Exchange Commission
promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/
Shearman&nbsp;&amp; Sterling LLP </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">LN/dy/gl/pp </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">HH </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>cvs-20200821.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-5 Build:20200707.2 -->
<!-- Creation date: 8/21/2020 11:19:36 PM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2019-01-31"
  xmlns:cvs="http://www.cvshealth.com/20200821"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.cvshealth.com/20200821"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20200821_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20200821_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.cvshealth.com//20200821/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>cvs-20200821_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-5 Build:20200707.2 -->
<!-- Creation date: 8/21/2020 11:19:36 PM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>cvs-20200821_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-5 Build:20200707.2 -->
<!-- Creation date: 8/21/2020 11:19:36 PM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cvshealth.com//20200821/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="cvs-20200821.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.cvshealth.com//20200821/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g5441546.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g5441546.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M;_\ "3:EH<?G:G:GPUXOT,VT?FB'>LOB/0+".X7S2!^X>3UZ<T 4/B'^U?\
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M$OA>._%H=2TO5]+TVU;4-*M]8F@C8-YT:FXMT2>8PMY)MY!MY'FWQH\>>/\
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MVNPQL),H;?(:=CR+X-?LU>-/ GQB\3?&[XG_ !E'Q=\8ZYX"LOAYICQ^ H_
M]KX?T&WUS^W[N"U@A\6ZPD\5Q?16K^7LA,;QRMO;SRJ&WR!O2UK6/23\%_\
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MWQUJ/QMJKO\ 9;*REA\DVO[S[3N,BF/#FWR#;Y'9_"KX+?\ "LO&?QL\6_\
M"2#6Q\8?'=KXV&G'1O[./AS[-HUKI#:9]L_M6Z_M?>+59?M'DV6W=M\HXW$V
,#8]SZ>V/PQB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g54415g27f51.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g54415g27f51.jpg
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M 0$! 0$! 0$! 0$!_\  $0@ ( #^ P$1  (1 0,1 ?_$ !\  0 " @(" P
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M0L@>:A,X>48#/F)%C@RD$2N:MH+'6S%:)K598IXKU&EV'R0=\U_A34@,P''
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M!S.;G8+]8Y6QL7<+[1<D"[[=14>850$[;[!1N -O3B5CKREY-X6O)+^ '+'
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M@,D'Q6>7I'9V^J+MQH@P($RQMZJ" ;?Y(O5__EAZ&_V+;)__ #7J-?U'FO\
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M5J>EXP>T[4(,E[W(SM*9$(C0V=EBNE%M&1P[+<26MUU"'V\H.%) "J[.IZ5
MVW&Y^[A5GDEZWMG'7/HM\IO,VYNJ96\W-O5:Z'H^%DIVTUX6QTF[S*KQ*!14
M'/DIK<836AH8Q[(C+>)&P1362D..MM/'"2KU'8L%[;[G^G!"O"UVUT_XLM!;
M2TY=?%AW9MF0V#N C9@LU5M0;"KP<<&]2ZG5L19 LMKTQ]XE+]<=+R0VXEK+
81+;?P^;:LY.%I%5R"'0=MO4?:?G\^/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>d54415d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cvs-20200821.xsd" xlink:type="simple"/>
    <context id="duration_2020-08-21_to_2020-08-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-08-21</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2020-08-21_to_2020-08-21"
      id="Hidden_dei_EntityRegistrantName">CVS HEALTH Corp</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2020-08-21_to_2020-08-21">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2020-08-21_to_2020-08-21"
      id="Hidden_dei_EntityCentralIndexKey">0000064803</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2020-08-21_to_2020-08-21">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2020-08-21_to_2020-08-21">2020-08-21</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2020-08-21_to_2020-08-21">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2020-08-21_to_2020-08-21">001-01011</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2020-08-21_to_2020-08-21">05-0494040</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2020-08-21_to_2020-08-21">One CVS Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2020-08-21_to_2020-08-21">Woonsocket</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2020-08-21_to_2020-08-21">RI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2020-08-21_to_2020-08-21">02895</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2020-08-21_to_2020-08-21">(401)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2020-08-21_to_2020-08-21">765-1500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2020-08-21_to_2020-08-21">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2020-08-21_to_2020-08-21">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2020-08-21_to_2020-08-21">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2020-08-21_to_2020-08-21">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2020-08-21_to_2020-08-21">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2020-08-21_to_2020-08-21">CVS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2020-08-21_to_2020-08-21">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2020-08-21_to_2020-08-21">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140215136482296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 21, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CVS HEALTH Corp<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000064803<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 21,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-01011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">05-0494040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One CVS Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Woonsocket<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">RI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(401)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">765-1500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CVS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M BHL""H+.P^^=I)*TM W.Y4QV:^W.YW;N RH#Z(ODSJGJD^=OD[6XR3AJ0-
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M>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ &X854660>9(9 0  SP,  !,
M  !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !
M8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB
M'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G
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M+GAM;%!+ 0(4 Q0    ( !N&%5%6E0G9[P   "L"   1              "
M :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( !N&%5&97)PC$ 8
M )PG   3              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L!
M A0#%     @ &X8549!9W\HH!   -A   !@              ("!#@@  'AL
M+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( !N&%5&#J:4#U $
M #(&   -              "  6P,  !X;"]S='EL97,N>&UL4$L! A0#%
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K  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  .\2      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d54415d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com//20200821/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d54415d8k.htm">d54415d8k.htm</File>
    <File>cvs-20200821.xsd</File>
    <File>cvs-20200821_lab.xml</File>
    <File>cvs-20200821_pre.xml</File>
    <File>d54415dex41.htm</File>
    <File>d54415dex42.htm</File>
    <File>d54415dex43.htm</File>
    <File>d54415dex51.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>g54415g27f51.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d54415d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d54415d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cvs-20200821_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cvs-20200821_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "cvs-20200821.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "cvs",
   "nsuri": "http://www.cvshealth.com/20200821",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d54415d8k.htm",
      "contextRef": "duration_2020-08-21_to_2020-08-21",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.cvshealth.com//20200821/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d54415d8k.htm",
      "contextRef": "duration_2020-08-21_to_2020-08-21",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200821/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200821/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200821/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200821/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200821/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200821/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200821/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200821/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200821/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200821/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200821/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200821/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200821/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200821/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200821/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200821/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200821/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200821/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200821/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200821/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200821/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200821/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001193125-20-227082-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-20-227082-xbrl.zip
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MLD209((T%=']P19M6&X05O62WW&IM\Q_P$AW\>3_0.@]_P%02P,$%     @
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M&14GOBUQ($1U.;YJV^'\'[91KJ*]U-QC@7V!<WW&_K.O(V+)7U!+ P04
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M,E$TXI!.@ZE@JIXR44$<9-#48ET?GF<.4D_P(?$!38K-\/<BWRV.60CO6%C
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M9Q_>K6VNT>^+SM&1^5V"Y,'YY5'WDJ[K-?"59P#^D\Y%O[MC_KASPU7H+
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MT,&P4#9Z@?4-L.[D7*X+B]<'W>N0\)5\B$8 \ZG1^-K61]?,;(EK9H$>A$\
M;RIN_D?S\+PT*__I+?LQ/,IA%C!ZE8+@+.(,/?SDFR(74P**VS4)T*I["C!<
MRVH1A5-2%-'5]+>M]LO-S?8F_U_(ZVN0!F1>51TIZQX)])&>DEB;WQN;;Q:H
MNU4C=G.2>:2+$IM%/<ID'OK,MDPK0)E%;);,:\F0N(TID,FIX9&24Y5S0!+-
MH8&NX+D(K110+D@DLQ;)\Q'IH=Y=@,3-EBR V:C4%NT-IZ]=L^$BV5WHC:ZY
MC:%Y;9L/REN:\FP8Q9&P/]J=.;58VQ\!61<!,4[SH <P1*0A[)*L):U->W+$
MOL(J1K.1^<H#;PGLI3A/R5A,[/.9C'C+D9*9&DI0AF6:HI)$1LO]4PE_INK.
M903&/^K9:1CD[.64PS#"W.0*NI+I%%,HA:1'"LP[!4V-@ R_<-&4[XV -N8(
MGB5<PA7D,F9T!PT)KN+"X(P43IH@SR:Y@7X','<?WY^J6N)\ID_R4HW4E'X\
MONISD88,PO\J8E7.?A?K9!4:RO#]J.VR>[HSFX&Y2$;6!6B=APAO#.F7])V2
MIQR("0\DF7') 7,'."C#'H"C*34UQTE^WR0E")74H&(&5U )B) (@$9CL;4)
M%P!7V(Z'"Z\V0?VXS=B*T[HXL2*:1,,=F%T NYI%1:9=5B/"["(F%Z0Q#ITA
MCC@T!-U>?4%%#%A,6ZL:=DC$VK90_RK0RF9><$U\B8SF];"E=4:01U0L0*2P
MG/N6]LU5%0PD11[2]= ,2"R1"QS8'ZXR5"JHGL+*A)1RI7&0#.S=48'.$>.6
M$*7*A9)-77(F51;!'#(IHA%G]JJR'X9*$*P?MME8AC-B'<^3]5LR"<MG3WJ7
MOU*[-G-L&M:5DVB)49B12V'I([@T22YV]K!K7_$Z<(UB2DM9P>-;XS!&+@;F
M%8Z0C$'K^V;G<<L,JYTZTH%P )B5%<#*/X4*#H#P&/1TW@$9N\")S\G'Y7Q@
MRXY@%5H57TFJS<:/I55'6$A XOOHYT>3/6(2(JK6,JQGOOK8"G5$CF K^Z>2
MK.5+_FKW?7MU_WUVCP,?=8U@LK#;>WWWC^DU+]>?I64BZJ%RZH0768U9C8?5
MOI!QF@VH&IE"9R_[-[7/8*9HC?#W#8"5MHU^,E8>M1XK78E6X!9D^91AUJCE
MEC'9<J>V/@FD=Q;9;9,:5,^"EY)_J\+*BQSTLW^C^[7B3.:]XOF2.8OJ:8!>
M=?2VLYH6%!D<EP0(@64.ET,J,9)!3M(V9%S&C<5P,F02$$^W_B_R.AOHAN:F
MA8^%6:Z]QF5(/4$L]TZTND#"K:)5>\%JJ.,4ALKH(-M.>R"BO %3\-KZ5YQ4
M:#8NK6/'+N)(@7Z?BO\I$F-PC$EA7B38MA85EM?1\)/P>D+B%BV$9*XH#((.
M>X=-J\S:+BLMH;,>EY-+,D0K Q:LYB3!@+[&2:$7;R=M-NZ:M0(PZ\I99<U_
M74_,JY^>F >@\3NQ=4%\',@TB !(P&AG8.Q'\$JP8<)>K"V,0V#O(3HA4/:2
MPIC"#R,+F-]65;^E JS-82VWQM"MT01<@)SR,"^,NF8#,F@]L_K-H1(7L--J
MX5/RUJ6TN@!SRR=K@=\6!\FXX^7(MOE,D+5]2*(1S"KZ,IADI2KS9$.<G!RB
MK4HNE##U_<NN9GY7[/7V3=X*)@ZV\<($..8-+A1_DYAES=(P;R2FZX3L,DH*
M"= 'HXLE)4I+$J9E+>0:,T5B.E9/4HZ8>X&,M<&X0Q25Z]+9[1=ZO*5@+)OM
MO";V)!'6*/:>DQ--^U.6#$DP=>R>=GSG\[X>]6='.T]$W"_=*15K^5"DUB]7
M +1%49)C;=0C1PHU'@I_:(C=R9W:!N&&X4AW=_A,719 0\FLMK&4M93U$4PK
M03=#9ERN8 N@Y/&5DGL-LZ5SM<2_ +R*%<PY8C=J(LD*^@( XA[9#O3W<F=S
MDY%RMC$%EE"F%E1UVT9A!N4Z';DLEY'TDU+J-*BGQ-:R1^"':)TV^<QE3I;<
M6\YUTFS C? &8 RG<4LN"7C&JNOW'7EU8L\#P\;O_0CZP"A9VK>O<2_5^Y>J
MV8_O>QZW$+ A1Q;^%%YHMQP/."P!ASK9:!KFB^) K*/^I,U2?<VEZ_RK(-^-
M?D6'U TQ5YX>*IAMW**0&+%H#NBZ>"[+8.,RVK!Q>."\<0+(J8VI""!CC)._
M;5-(#1UFWJMD]F(D'OU(24P)'YAMA_9L$>7A+&([]V];^#;YCCC)*RO&8["6
M=5H9-<&I<PRA5>/YAGS?+<)3<VST[+.;SN;SM9J-\B9=GX\%MQ6PW20C)<1$
MU,II20OI=-4Q2F$CT@2").;8EHZW T SSOIB!X.V1HF$>!DV8PN5),Z^L]XJ
M>LSME=W&U0WKAD2@>%/;(+/"QZ?(ZQ:0WZQ(@XG,5-G!<S4CM_0AIRG!K4,8
M*4TBP.?P&E -8=Z],8FGCYO\-5YM8>O2I7$,593,6R()0%$%SNZE3;@MD^/1
M96]@]PX\7"3H4*.3"Q(V&ZF#G.^$1A);#SFQ[QICY374)8J98>()S!-R"YRR
M-&CIQ84FRQ-FRPH9VPAO,L;(XTB9C!+:8B4%:!%*Y_B6IVE;)8,"V:[7#N6E
MV+XZ/<V\:#@*&Y7&*ZOKQ@6L 4<RF!=KW:_8DRN;^,[TK16=Z0P+!_NO\:*7
MPDC>$$O]ZR9_R#S9;-P'7IV-74HH^@BL"G;\@H,, -\(#LK$F.['X_N!R[FD
M)FX!%Q:R@C26&&<:23;)/E14:=Q/G;Z+L2-G:H%Z<3^U438SGK+6DSWR<$#W
M\[)<3J[.@>+UMW4=!SUC=ANC 9-&H1%Q!I8Z=A#)W-QY9:!L*D5X+N3#?U4O
MVNN?7K1OKVQO-C194,@GQ(#SBC2\F$I0Y<"S- $KK$A5YLB1M#Y;]@7HZ1BT
M202OR\NEO'X,,42W7K*0'M4&G2^+:(4([M;OZMF6B=FZQ*+N%YUSC%F5QMYG
M'<CSWT1RSF0%/+B(I*>XZ)%XZR"_22&D?,':=U"9\MR%R/*3.-:!&ZN]I?7J
M!V478_0U ^')95/WLR" :&5Q6D,O=Y<CCU)EP]R^T:X=5CJ&A>=NG8NS5UO6
ME<S5N[AUY91+9MQ]!X&_:4R,WV*Z@\Z!2%AO0:K&O H.G'LI>0X+5MX(8O)-
MF.:%LOD/!BR\#MI'Z()NL. G<#R<QTNVY5/QW8?2KB U;&1<1'AUYX[6<*^^
MN<W%C^UD[#7"J/;+J/;3\%FW*>XG)B_>B67E_6N5'A8O?ZTKR=<W7X!(J.L6
MS'R>NY[6O+95>:UF G^@Q:8)I;L:O*)\.&*Y*%FU<P'HF%C$YM<L.<L6J&BF
M4J!KKFQ"O;0B+9;HXKNBW'3!-"SXB74_L0[/4KL\EC@\0./5ME')-;B<'8(<
M-MY7'8?6FGG:;%A'A;4;%K!ZEUA_/<;6M@/ZB;#_>0@;A3=<6TOM5TW/5;[L
MTB"-8]1I'!;;F-/2HSK?G; ?D/T<?9%@VK+_% Q3[D<4D)&'P3!MX:[B1/!]
MD?8BI^A9U\#&_;C^^(T:0/G##N<5'\!G5:LEDY#AC&7R&@5^?O]*?C1TG^@@
M%'JW;FFN3*??Q-JUHVUX6'"LTE+*%FN+KER*+(&RZLB6@&?K<&A7#TVIA.Q-
M=U6XII+ 7Y<S)K([);,IX<*Y1ZF<QUH_)JT9IR2'EZEYJ%$>\67?_0?7M5]^
MS+82M9+0H.;Y0K(J #\+RJ]816M%"*@;3L9L-G3M?%VE2%N;<>0 D:;*WAQ)
M):-S^9S%JB[?)U#SWR^4!'A)"VW]T_C5R.D;UIFABPK]0_O8K9_A@-RS7K3X
M0XIX?<D\B^!:D_I92J2DVCZJ,&)?+R5ZUH\'Y$+A) TJOMILH-(0A)R_N> ;
MCPF1.0);\IZ9E'ZNSH]MT RQS97H&,\AIF]JPSVLQR?@PF'$%A<Y#>G/>]T:
MY11WD_=K#WUA=<0NRNRN'O_7V>'X;0NPT4(R'K%73):(**&B<A.YYA1\[R!#
M8Y'SHE'BQ3$(IT"-.&T?[G$U.AD;29:%Z$,9)?/X.M7<T,O>T6=N#K<%<G&U
M)" I5L!*CW7+-,PT=CG7@"3N&P9%)"F:5;"+!Q5-'N4.AX5ED16UU!^RYL"8
M^1=9S=#-QFJ;6JPQ4A[?H-GNY8,M4VI2.0 4D$81J0.([55$GD)O5LY]]N ]
M0T_1*.%T?8TBI+<8O$&7#&;OH?H>QK"I:4FW\E)7ZJ/5.J%!/U^)83O^XW8Q
M-VA-%-YV060JC:-S:QLOFQ9>H >&:5!,,;DOX-9(@$>**!_EO$:JLL>OK0=T
M6-&N>,O< :%68$FYU-AEV1OV2,MRNIQGCG^O@$JMOVY^[IN?D86'R,&O8EEM
M24=%$?=S,;5(VVDVUK>\S$4F)]:3#7L9AY&6+IQ(A0:-EBV.?D"BD!76US5W
M8NO%T4H].K9^/W*1A*H_JQ1/P"JW*&'AH&*%"2-@<8&\ EMM$LYP@2HDRGR)
M95.Z^*I<>JNY3[.!O>(PER)/L",.5B4E16Y3@Y,5QL!J:5(*DCE#8ODC];/L
MBO5MK]9A!)9)D#-(]=]8K]RV%<#8X Z8Q*W4#)H5<H *.6^HKXRGHV,[(TD'
M3K7%*;%O5W4,C[>(LU)'2&K28#M IBHB#="/V;:-*Z=:@LP7:P'$5A$7M]2"
M1Q<M&SM+_]2EUJ748Z^^.P?+,&9.SE(!0_^\"3JLF>[RY:F?E%]9,F=:OCGC
MVUX(5^Z162WWWJ6RCA?>B8%4S'+*E42A1=(6BYW^F?B9@%,U'7II(!4('"0R
M)2%U1"=.'R1+*4Q-A*U-.7OS":PBT";1AK6D4;&*9"G07Z^&A?%-@G6A=7HZ
M:#>6 ?GG,%1!0G:]HPL\1?UC3JV#GB74.L@>TBWK=7"/5AIX9CQ0VGJG)9;0
MV:2<JE.B6A.8JH[JMP9S%@)K,QY$='\5CUYP!NKKH+6<RN2U'*39X,64F\;I
M\O:%.1%/#TSUT6K+C!---R4>L@A+3EV[=9IG.7A,RB;69*/,::$-@D]5N75;
MGT%TZY\"-MI";F4K9HD#C[F7S"I'\I25EO?J\2O(9UC6Q*<1IW)2)'T5/?%)
MBTT7V-5B9K:TT7%C])OD?ON!QMMF@UGFZAP3^SE:)C(GR>"&($RI>:FF?1-6
M:4K/C"=#FMG^MC>ZSHGEEJW"%HJ:OYGG+9O6#\F#\2Q)=DK8<T5LU'%_VN@<
M77^>4%DV4;6@E;-"#*2%O_)UK3:AQ6]2I@)N!I/P56^M]7+^RZW7Y"DTTI![
M$O)1$.3DU"2MTU*4XOQ45VSK&#YF/YLN<PDUY\$'#&3=3NYL&/W .+^$%A=H
M71JKW ;04)I1N:GFM =2OJ!L7O)8V0*#%D+_-$E&3F7"T-A].O7!P<$SHU(O
M&;1/)5\73UG&X>]K 62E33.<$:O[*KVA!#XN<DO2\N=<G[2&JNR@62S8,QS*
M.$T7SE6?R:[16&S]L+;<2B_ UO7S+DF\V: :%B\7,A5C&4:9%[VI\Q4Z%Z'K
M<4KI2I(T:;19['<P%Z@_8"&%JB##PE1:1K?4BO8ZY@;S&#GC1I!V#>FUA)OT
MN ;5G/-867&F?G8V)^W%NFRMO]INU:2;-1MH'RZIJR-#P'Q3A)L7H&V11+8T
M="4ITS+.HUD$I,:9&7C4MP2J)4=#&$IRG:>9MHW6%TAJ78B*[E,BK5[G K(:
MU/H0)4,LH*$#0P$.W)DSN7!'E:?NHLF_HNOJ[4_7U0\L!)FTQ)%?3[0+.C([
M-G:=G^=)^J.ZR!<YLVPK9')U&QTD2#!V65,6A1477 UE^DDM+<G YJ%? NX1
M1&4Z&UX:O>G;ATS!]:"F'A4,&UN656U%4O)L<,ZOZY.+PYGR$EDM_6ICP@+R
M6&WS,9&#L!@7:1QF$];\P-*D!N3Q"/B@,?92M\A1$A1\E3PY7,!%)2SRBP[-
MCU4E@3F2<\X'0NW?+W];NA'0%D<Z*LXGQ/JMUZW;!Y:+EUNQ4*Z$,@WCVR:&
M'>@$8>E_Q;=:V:8_M[[8!8I# :5W6J9>Q^O':$)Z>-Q;+YFI42V!KB>37N>9
M)?5Y.&KMJUZC[W)C]\<N^0I;MM7^$2_YG)RT3T/="UW^K:."SDV7,'I]-<E!
M0^$F7+4UGNCI:E/-)VB3_L^6N(J#2(8(V%,JGWQL ZAONZ4V&U[H2PZ!U).8
MBNW)\TMD3K517.9I&VIY[?AMZA3WO63\Y69'&,$V&Z57YPFUG=,)\+;J-2WG
M*[IOCI :23-3KT^3N&C\@KGV,W,@LHBI>QNZO6KWX3Z!A*4#IB>$[K'9H0).
M\I!Y7?Q<$2#\P"^$VL0T7A559$1)\IF+9:OKTRE$E5RVZG:]7.$GP,;/(-7#
M#)AN>LVU*$=J#&8#":=')W>'E[8 UY7>MJN';]O\D<357B@D_2E'1#BNL;S,
M0:L-.GCA=< =E]/(=':MY_LQ1ZF_<)%2TW'QP34[.?<FO)-HEK>PI/(X*^PP
M.*);%'RU"?(PB!.U1 ?V,\(][8J/DO(YGXB1476XP1A6"PCTE5+54CI<J4^9
M._Q2\Q M6^24LW;L^6.^1*X(.3,O;<XKJ90Y]2C._8 2]Y2K))KZ0<N2UW*Q
M*XW)V<-D"9L<V6SHM-=;5Z1CUCW'0_FZ9=^S6M_I4 V';H@:\EWQ,(R23FCM
M5H>[<C)?NOZ^BSF>EB11=<7S$G><*RZ0NV?CP\/PNB"ZPJ^W9>3&!E#;&)/N
MD4JN HJ[C!+%S3&G6%*J@ZCHX1\!"63TJ1G^P@!%6+!$/%N^&0X!^?5>'<QJ
MBG3#XY<&YG8GS<;B*XMA'"7ZW<-E!77HQ.2$:$\)=J!R''+0ZSR^]CE%.Y,P
M/=,?2\$(& KMQ^8NU!K5)+B-S:IT@X#%C-T%K6893]A^^2N9@:MUA,78 A(_
M:%(IMQ$H(;)N:$S?0S)?$W(QPPUQ:"CQQF '-EA+BUD>Z/!=AL%=Q&X<OVL?
M,]OE4 !%AEW*IEL")\/?L81E>>6D:"U,]]?U-FUM_G0W_3C:6VA/@$2 3%=A
M!F.@[F+O^DMR,G,?9PQU:^^*=\*7&JD:ZTJ4%:;0QD;('Y@$,9M1.\-I3"%
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MYXN[3<^]YP?G1Y_@XO'@]&3__P%02P,$%     @ &X854;6J5NP:)P  2K\
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MB7!$(P 2W>*RR'(><+/3IN-;%_V)( C-)&PTS*_%6,+QAIF(DQQ@NE=D80Q
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M0,H'"397 7H$QH9W:7CZ<H#H7S^!"[7/$+=RN#Y#6/GP*D$')PBF*OAD>0U
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M6NA!+]!R4Q[&ZX> SZIL.:?W$YR.\TE6PTDVSJ)=VRYRHZ,L96]XSOYO"J
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M !J_$5L7Q,>>3(,(@ 2,=@;V?@2/!&LF\H4X"+(S!/8>HA\"92_IBRE\,;*
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M+>]_4[=WC?C<G"#5!'J WFA?IE0HRU+82PZ* Z,/(%"6E"<* +.A(-:OLB@
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M%Q#PVYVN5<,*O[.SL[&]<[#7W'^3#T%+G%^,4=6**#"NRT([#;>Q=7&+K2=
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MDUOK')C%&PVV^1G4.X4/L-3VL,>$(0YW\+]D6>$_/B001-5Q'YJ1HD2#WG#
MC*;\2N%=3X6[EQYU6$+V3!)$+1K7ST[]GI(===CLH4PRZ=]*[T[]GM8[<Q+*
M.;Q_Z_W*QGZMY_ @-C03H#L!"H.A4+F,0J6-P638.$P7@Z=@,-@ 3<$(:GCV
MB(5'3R \>E3 EH0E# 9%X7)+&00BH^A@,G#YPH/#:-D\QNC 4!0JXX>"P00(
M% ;;Q7692$(W@Z<N5K ")H8 ;[0I.$R&AL.T:;A,FXO'5!B$K*B-Q[39Q&R&
M5\2*>D5%@&PF0\)F1 M_%&P&1<YAP#(V4Z+F,A5J3BQJXL6"9GX,MO[K)\KA
M,Z-F*9M!-. ]&'AVC9*K]!:U%0'^0OB__ %@?*(*&T. 3Y<1Y2B+I\P0*!D*
MB1*?&H>!" HGR6<4SD[!8?S[4' 940$/7Q8^B^'"IX>WV03L#^7>K2&#A<\6
M7Q>S@*7PBO%F%MX!FV%3L/!S^(K@0)@$WRR)DLE@< 5*04RAY? X)([#;.!H
M)#Z>G1G3Q10..;,(4!/BVR4QHP-F*>.V",>M2"C5+K\H;B#+65*- G-190FI
MW:(Q\M5L8E@@$'HE0I;=9K0+\:7SJXC:D%0K8@;B%$#.*0($96JB4:_CNA$=
M&+/HW72=D63W(9Y0T*2#(@:R$K1@%@JJ]]&L?)!@)<LX=@/"=P@\(@<E+G5Z
M"2P7I-*Z?:C!8RP"])LP(0G%()'3)])Y?%2'S^\/!P,(->)5XNN+3U_ 9BIP
MNB@,'!9."%/AFMDY;":+HY)H.%R-4FH7V(PQFY$3+P+TFOA1KH2OI*BD+*Y6
MZ#!'. DA6\FVV1&5)JYS&&AB%I,L5TE1(<<6LVA<45O1E(5.(Y?GL+@L7 T9
M]LL2T;C-5P1(),@3=J'*%9*H-9!<Z;88=%J?2<\%43VH=!L]%B^B\P5,/#!L
M(OW1](L "6RW4*=S0PZCQQ<V8T:JU>67N7P(@OE%'K^?&@\%_(0(@.!$8Q<R
M@E-(,3;,H%H()BL49JMB8B_?34#"/IZ_"%#OIMJ!L)S+$0!D(P6C8Q!=PM90
M,0)/3)('Z30Y*M:9)'(ET0G(X 1DM=+"5@Z=#\>0A)?@]_G==HM*J?>'XHC:
M502H3I#]2@&;'I22F0FF4V C\<-TM1?6F?@4,\46(]#(E@2)KXT0S#:3%A"Y
M3%0+PP!(S!2).:AF>$0,FRENPV@&J=56;'IDNA0FZ8)"9XBNCNDPNLO(UG#4
M4HHR L7AB#A!2,0IQ' 8B8;]5I]!'XR"<HR*@0D/V6\.AU"]7L)+6"(F3$6)
M%#L'6&[G,^/^$$8T$K0 Y-5%/&&0Z[1R#5+4I@NZ#"2=10FZG'PGP&"+202=
M2:VF.ITD.6A%"49ZF&Y7$5UA&8_  8H C1"?SE3+X5A$'O)!<J)!C[L9JMW"
M]=)X)+DBR-2$ 8+"K=13F2ZZTD-A0NX8&@O'C0A9'(6]2H(7\-(AJQ2-P,6V
MC/$3X@ ]"I/\B%TJX0L%-HAKT#)I8IY() \GM&J/T9PP4>T^6<+,P[@&B@VU
MZB&?B2]$21I_/!82FE1$2$!U>TG%M$$I B]B9,9]+$Y,Z5<03$1G7$M >"&]
MBT-VF_1BDD['UW@3)IW,YXX+::@E%G,8?4RE1X^I?$*_G.<Q<B2PGZ*R.(H
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M#+ F3/,@<!@*^ VPC^90^HQL2IC&=1)P!XQ"L2A'X!! #"V,^>20EZ R112
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M+S[;+KR$9QAY; ZG,*RPU\3A63\F/]@?T'"SMGQP4QK38<3)C-&1LI1K;'2
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M57((=!VV]1]I^?SX_]E02P$"% ,4    "  ;AA51N2C=UV$#   G#   $
M            @ $     8W9S+3(P,C P.#(Q+GAS9%!+ 0(4 Q0    ( !N&
M%5%OM;G]9P8  $E$   4              "  8\#  !C=G,M,C R,# X,C%?
M;&%B+GAM;%!+ 0(4 Q0    ( !N&%5')[!O$O 0   @K   4
M  "  2@*  !C=G,M,C R,# X,C%?<')E+GAM;%!+ 0(4 Q0    ( !N&%5%W
M6#:VVA   +]U   -              "  18/  !D-30T,35D.&LN:'1M4$L!
M A0#%     @ &X8545-.%NC])@  (KX   \              ( !&R   &0U
M-#0Q-61E>#0Q+FAT;5!+ 0(4 Q0    ( !N&%5&UJE;L&B<  $J_   /
M          "  45'  !D-30T,35D97@T,BYH=&U02P$"% ,4    "  ;AA51
MX5^I??HF  !HNP  #P              @ &,;@  9#4T-#$U9&5X-#,N:'1M
M4$L! A0#%     @ &X8549(G&(DM#@  &4H   \              ( !LY4
M &0U-#0Q-61E>#4Q+FAT;5!+ 0(4 Q0    ( !N&%5%;$NAQ)E,  #JP   0
M              "  0VD  !G-30T,35G,C=F-3$N:G!G4$L%!@     )  D
*+P(  &'W      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
